Araştırma Makalesi

Can lymphocyte to monocyte ratio be used as a predictor of atherosclerotic carotid plaques in elderly adults?

Cilt: 40 Sayı: 2 5 Haziran 2018
PDF İndir
EN TR

Can lymphocyte to monocyte ratio be used as a predictor of atherosclerotic carotid plaques in elderly adults?

Abstract

Introduction: The lymphocyte/ monocyte ratio(LMR), a novel marker of inflammation, has been accepted as a predictor for atherosclerosis. However, the relationship between LMR and carotid atherosclerotic stenosis in older healthy adults remains undefined.

Aim: The aim of our study was to determine retrospectively the association of LMR with carotid stenosis, evaluated by carotid artery doppler ultrasonography.

Materials and Methods: Our study included 102 patients, aged ≥ 65 years,hospitalized in our clinic from January 2011 to December 2017.  Blood samples were taken from all of the patients to determine the levels of white blood cell subtypes. LMR was calculated as the ratio of lymphocyte count to monocyte count. Patients also underwent carotid artery doppler ultrasonography to define the presence of carotid stenosis.

Results:After dividing the patient group into two subgroups according to carotid stenosis, the patients with severe stenosis(carotid stenosis> 50% )(n=42) had lower lymphocyte count and LMR value but higher monocyte count. Then the patient group with carotid stenosis> 50% were divided into two subgroups again. While a statistically significant difference was found between the LMR values ​​of these 3 groups, this difference was in favor of the first group(carotis stenosis ˂50%). The optimum cut-off LMR values was determined as 2.49 with a sensitivity of 72.6% and a specificity of 80.7%.

Conclusion: Lower levels of LMR can be used as a strong predictor of the presence of severe carotid stenosis in elderly adults.

Keywords

Kaynakça

  1. 1. Balkan S. editör. 3 rd ed.Serebrovasküler hastalıklar. vols 46-61. 3 rd ed. Ankara; 2002.p236-255.
  2. 2. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J,Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
  3. 3. Pagram H, Bivard A, Lincz LF, Levi C. Peripheral immune cell counts and advanced imaging as biomarkers of stroke outcome. Cerebrovasc Dis Extra, 2016; 6: 120–128.
  4. 4. Ross R. Atherosclerosis –an inflmamatory disease. N engl J Med 1999;340:115-126.
  5. 5. Tuttolomondo A,Di Raimondo D, Pecoraro R,Serio A, Aguanno G, Pinto A,et al. Immune-inflmammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. Atherosclerosis 2012;213(1):311-318.
  6. 6. Kim J, Song TJ, Park JH, Lee HS. Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction. Atherosclerosis, 2012; 222: 464–467.
  7. 7. Bolayir A, Cigdem B, Gokce SF,Bolayir HA, Kayim Yildiz O,Bolayir E,et al. The Effect of Eosinopenia on Mortality in Patients with Intracerebral Hemorrhage. Journal of Stroke and Cerebrovascular Disease 2017;10(26):2248- 2255.
  8. 8. Rodrigues SF, Granger DN. Leukocyte-mediated tissue injury in ischemic stroke. Curr Med Chem, 2014; 21: 2130–2137.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yazarlar

Asli Bolayir *
Sivas Cumhuriyet University Neurology Department
0000-0001-6566-3751
Türkiye

Yayımlanma Tarihi

5 Haziran 2018

Gönderilme Tarihi

15 Mart 2018

Kabul Tarihi

15 Mayıs 2018

Yayımlandığı Sayı

Yıl 2018 Cilt: 40 Sayı: 2

Kaynak Göster

AMA
1.Bolayir A, Bolayir E. Can lymphocyte to monocyte ratio be used as a predictor of atherosclerotic carotid plaques in elderly adults? CMJ. 2018;40(2):120-127. doi:10.7197/223.v40i37154.406575

Cited By